On the call are Rene Haas, Arm Holdings plc American Depositary Shares' Chief Executive, and Jason Child, Arm Holdings plc ...

The Alliance for Regenerative Medicine (ARM), the advocacy voice for regenerative medicine, issued the following statement about the FDA's release of a clinical hold on Geron's human embryonic stem ...

Qualcomm 's central processors are properly licensed under an agreement with Arm Holdings, a jury found in a trial in U.S. federal court that removed some, but not all, uncertainty around the mobile ...

Arm Holdings plc American Depositary Shares (NASDAQ:ARM) Q3 2026 Earnings Call Transcript February 4, 2026 Arm Holdings plc American Depositary Shares misses on earnings expectations. Reported EPS is ...

Good day, and thank you for standing by. Welcome to the Arm Second Quarter Fiscal Year 2026 Webcast and Conference Call. [Operator Instructions] Please be advised that today's conference is being ...

With the end of testimony on day 3 of the Qualcomm/Arm trial, the only items remaining were the closing arguments, instructions for the jury and their deliberations. The jury didn’t reach a verdict ...

Arm dominates mobile chip architecture through licensing/royalties but faces rising competition from RISC-V and potential customer defection, as major tech companies develop in-house solutions. $500B ...